Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 200

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Regulatory T cell-targeted hybrid nanoparticles combined with immuno-checkpoint blockage for cancer immunotherapy

Ou, Wenquan, Thapa, Raj Kumar, Jiang, Liyuan, Soe, Zar Chi, Gautam, Milan, Chang, Jae-Hoon, Jeong, Jee-Heon, Ku, Sae Kwang, Choi, Han-Gon, Yong, Chul Soon, Kim, Jong Oh·2018·Journal of Controlled Release

Abstract

ABSTRACT Immunosuppression in tumor microenvironments induced by regulatory T (Treg) cells is regarded a critical mechanism of tumor immune escape and poses a major impediment to cancer immunotherapy. In this study, we developed tLyp1 peptide‐conjugated hybrid nanoparticles for targeting Treg cells in the tumor microenvironment. The tLyp1 peptide‐modified hybrid nanoparticles presented good stability and effective targeting to Treg cells, and they enhanced the effect of imatinib in downregulating Treg cell suppression through inhibition of STAT3 and STAT5 phosphorylation. In addition, an in vivo study revealed high tumor accumulation of the hybrid nanoparticle. Specifically, prolonged survival rate, enhanced tumor inhibition, reduced intratumoral Treg cells, and elevated intratumoral CD8+ T cells against tumor were observed when combined with checkpoint‐blockade by using anti‐cytotoxic T‐lymphocyte antigen‐4 antibody. This study provided groundwork for a repertoire of nanoparticle‐based drugs for targeting and modulating Treg cell function in the tumor microenvironment and for improving antitumor immunotherapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jconrel.2018.05.018

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 200

Metadata

Authors
Ou, W., Thapa, R. K., Jiang, L., Soe, Z. C., Gautam, M., Chang, J.-H., Jeong, J.-H., Ku, S. K., Choi, H.-G., Yong, C. S., & Kim, J. O.
Venue
Journal of Controlled Release
Publisher
Elsevier BV
Published
2018-07
Volume
281
Pages
84-96
ISSN
0168-3659 (ISSN-L)
OpenAlex
W2803289916
Cited by
200
References
6
FWCI
6.89
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Regulatory T cell-targeted hybrid nanoparticles combined with immuno-checkpoint blockage for cancer immunotherapy. https://app.cochat.ai/papers/10.1016/j.jconrel.2018.05.018
The paper
Ou, W., Thapa, R. K., Jiang, L., Soe, Z. C., Gautam, M., Chang, J.-H., Jeong, J.-H., Ku, S. K., Choi, H.-G., Yong, C. S., & Kim, J. O. (2018). Regulatory T cell-targeted hybrid nanoparticles combined with immuno-checkpoint blockage for cancer immunotherapy. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2018.05.018

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.